Navigation Links
EASL-AASLD Special Conference on Therapy of Hepatitis C
Date:6/28/2012

The European Association for the Study of the Liver (EASL), together with the American Association for the Study of Liver Diseases (AASLD), will be holding an exciting "Special Conference" dedicated to the timely topic of:

Therapy of Hepatitis C: Clinical Application and Drug Development

During the three days of the conference held from 14-16 September 2012 in Prague, Czech Republic leading international Hepatitis C experts will highlight and address a series of lectures, and participate in interactive debates on hop topics in Hepatitis C. Case presentations and parallel interactive sessions will take place and space will be reserved for poster presentations of original works in the field.

The EASL-AASLD Special Conference provides an opportunity to keep abreast of the latest developments in this rapidly advancing field. The programme has been designed to provide adequate time for discussion and networking and will address a variety of areas including:

  • Global scale intervention and control of HCV
  • Prospects for a preventive HCV vaccine
  • Review of new drug treatments in development such as Nonnucleoside inhibitors of HCV RNA polymerase, NS5A inhibitors, and Cyclophylin inhibitors
  • Effectiveness of triple combinations in cirrhotics

Prof. Dr. Heiner Wedemeyer, a former EASL Secretary General and one of the Special Conference organisers, said a major discussion point at the conference will deal with the real-world use of new direct-acting antivirals (DAAs):

"We will discuss how to manage the side-effects of DDAs in real-world settings, and also their efficacy in populations not treated in pivotal registration trials. This is extremely important for physicians who are starting to use the drugs, particularly in terms of which patients should now be treated," said Prof. Dr. Heiner Wedemeyer.

Moreover, Prof. Dr. Wedemeyer said perspectives on Interferon (IFN) free treatment regimens will be extremely exciting: "After more than 25 years, we can now develop therapies that will not require IFN-alpha, which causes many side-effects and is also very expensive. We are experiencing a paradigm shift in the therapy of hepatitis C. This conference will also be very important for the development of new guidelines in Europe!"


'/>"/>

Contact: Travis Taylor
easlpressoffice@cohnwolfe.com
44-207-331-5472
European Association for the Study of the Liver
Source:Eurekalert

Related medicine news :

1. High Blood Pressure May Be Especially Lethal for Blacks
2. Internal medicine physician specialists release policy paper on reforming Medicaid
3. Being left out puts youths with special needs at risk for depression
4. Gastroenterology special issue focuses on new directions of viral hepatitis care and research
5. Specialized care by experienced teams cuts death and disability from bleeding brain aneurysms
6. Prenatal exposure to pollution especially dangerous for children with asthma
7. Hospital volume and surgeon specialty influence patient outcomes
8. Ethics should drive health policy reform, especially with physician-owned specialty hospitals
9. U.S.A. Hurdle Specialist Kellie Wells has Joined Elite Athletes Tiger Woods, Hines Ward and Takaishi Saito in Using Cell Therapy
10. Nassau County’s Special Districts and Service Providers Mapped for the First Time
11. Elsevier organizes label-free technologies conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... Chuck E. ... Sensory Sensitive Sundays, a joint event at Chuck E. Cheese’s locations throughout New England, ... other special needs, the opportunity to experience the fun of visiting Chuck E. Cheese’s ...
(Date:2/19/2017)... Carolina (PRWEB) , ... February 19, 2017 , ... The ... evening undergraduate nursing students, is being led by Amelia Joseph, Ph.D. Joseph was engaged ... initial operations of the nursing department in early 2016. After a nation-wide search, she ...
(Date:2/19/2017)... ... February 19, 2017 , ... "At your fingertips" electronic ... MEDfx and the Delaware Health Information Network (DHIN) have partnered to improve connectivity ... state-wide health information exchange, DHIN stores and shares real-time health data for more ...
(Date:2/18/2017)... ... February 17, 2017 , ... Focused start-ups, ... in the industry, according to the recent NEJM Catalyst Insights Report on the ... the NEJM Catalyst Insights Council, a qualified group of U.S. executives, clinical leaders, ...
(Date:2/18/2017)... ... ... Park Cities Pet Sitter President, Joette White, has been featured on Episode ... The episode, which was posted this week, features a 30-minute interview of White by ... Pet Sitter’s being awarded the 2017 National Association of Professional Pet Sitter’s Business of ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... 20, 2017 Adequate intake of ... phosphorous minerals in one,s body. Consumers are well aware ... maintaining a healthy composition of bones and teeth. Consumption ... is growing in the world. Medical research and clinical ... ingredients for treatment of prevalent disorders such as multiple ...
(Date:2/19/2017)... Texas , Feb. 19, 2017   AC ... evaluation, selection, and ranking of vendors in the PMS/EHR ... technologies and implementational system requirements to succeed in this ... AC Group gathered together information obtained from over 200 ... 100 technology software and services companies that are providing ...
(Date:2/19/2017)... 2017 Marapharm (OTCQB: MRPHF) (CSE: ... Medical Delivery Service with the specific and limited purpose ... patients and caregivers. The delivery service is located in ... Coachella Valley, California . The Valley ... area to the West, population 19,000,000. The population ...
Breaking Medicine Technology: